6-Benzhydrylidene-8-(4-nitro-phenyl)-tricyclo[3.2.1.02,7]-
oct-3-en-1-yl]-phenyl-methanone (2a)
J = 7.0 Hz, 2 H), 6.79–6.77 (m, 1 H), 6.85 (d, J = 8.0 Hz, 2 H),
7.04–6.99 (m, 3 H), 7.24–7.13 (m, 3 H), 7.30–7.27 (m, 1 H), 7.39–
7.36 (m, 2 H), 7.50–7.47 (m, 2 H), 7.61–7.58 (m, 3 H), 7.65 (d,
J = 8.0 Hz, 2 H), 8.01 (d, J = 7.0 Hz, 2 H). 13C NMR (125 MHz,
CDCl3): d 51.9 (CH), 53.5 (CH3), 58.2 (CH), 65.7 (Cquat), 123.6
(CH), 126.6 (CH), 126.7 (CH), 126.7 (CH), 127.1 (CH), 127.5
(CH), 128.2 (CH), 128.2 (CH), 128.6 (Cquat), 128.8 (CH), 128.9
(CH), 128.9 (CH), 129.2 (CH), 129.4 (CH), 130.5 (CH), 133.6
(CH), 137.8 (Cquat), 140.9 (Cquat), 141.4 (Cquat), 143.8 (Cquat), 144.7
(Cquat), 149.3 (Cquat), 166.9 (Cquat), 198.6 (Cquat). EI MS (70 eV, m/z
(%)): 508 (M+, 52), 403 (M+ − C6H5CO, 100); HRMS (70 eV, EI)
calcd for C36H28O3: 508.2038; found, 508.2015. IR (KBr) mmax 1722,
1682, 1600 cm−1. Anal. calcd. for C36H28O3 (508.6): C, 85.01; H,
555; found: C, 85.05; H, 5.59%.
Mp. 174–176 ◦C. 1H NMR (300 MHz, CDCl3): d 2.95–2.92 (m, 1
H), 3.25–3.21 (m, 1 H), 3.65–3.61 (m, 1 H), 4.14 (d, J = 6.0 Hz, 1
H), 5.61–5.55 (m, 1 H), 6.27–7.22 (m, 1 H), 7.17 (d, J = 7.8 Hz, 2
H), 7.51–7.24 (m, 13 H), 7.71–7.68 (m, 2 H), 7.97 (d, J = 9.0 Hz,
2 H). 13C NMR (125 MHz, CDCl3): d 27.5 (CH), 33.2 (CH),
43.3 (Cquat), 45.8 (CH), 46.8 (CH), 123.0 (CH), 125.2 (CH), 126.1
(CH), 127.2 (CH), 127.4 (CH), 127.5 (CH), 128.2 (CH), 128.3
(CH), 128.5 (CH), 129.1 (CH), 129.7 (CH), 129.8 (CH), 132.3
(CH), 136.3 (Cquat), 137.0 (Cquat), 138.2 (Cquat), 141.6 (Cquat), 146.2
(Cquat), 146.5 (Cquat), 199.9 (Cquat). EI MS (70 eV, m/z (%)): 495 (M+,
+
100), 165 (C13H9 , 51); HRMS (70 eV, EI) calcd. for C34H25NO3:
495.1834; found, 495.1822. IR (KBr) 1666, 1598, 1517 cm−1. Anal.
calcd. for C34H25NO3 (495.6): C, 82.40; H, 5.08; N, 2.83; found: C,
82.04; H, 5.52; N, 2.69%.
Phenyl-(2,3,3-triphenyl-indan-1-yl)-methanone (3b)
◦
1
Mp. 178–179 C. H NMR (300 MHz, CDCl3): d 5.35 (d, J =
10.5 Hz, 1 H), 5.59 (d, J = 9.9 Hz, 1 H), 6.35–6.32 (m, 2 H),
6.79–6.74 (m, 3 H), 7.04–6.94 (m, 6 H), 7.23–7.12 (m, 3 H), 7.29–
7.27 (m, 1 H), 7.39–7.34 (m, 2 H), 7.50–7.45 (m, 2 H), 7.63–7.58
(m, 3 H), 8.03–8.00 (m, 2 H). 13C NMR (75 MHz, CDCl3): d
53.5 (CH), 58.3 (CH), 65.5 (Cquat), 123.6 (CH), 126.4 (CH), 126.5
(CH), 126.6 (CH), 126.8 (CH), 127.4 (CH), 127.6 (CH), 128.0
(CH), 128.0 (CH), 128.8 (CH), 128.9 (CH), 129.3 (CH), 130.6
(CH), 133.4 (CH), 138.0 (Cquat), 138.1 (Cquat), 141.2 (Cquat), 141.8
(Cquat), 145.1 (Cquat), 149.6 (Cquat), 199.0 (Cquat). EI MS (70 eV, m/z
(%)): 450 (M+, 51), 345 (M+ − C6H5CO, 100); HRMS (70 eV, EI)
calcd for C34H26O: 450.1984; found, 450.2014. IR (KBr) mmax 1686,
1579 cm−1. Anal. calcd. for C34H26O (450.6): C, 90.63; H, 5.82;
found: C, 90.41; H, 5.91%.
4-(8-Benzhydrylidene-7-benzoyl-tricyclo[3.2.1.02,7]oct-3-en-6-yl)-
benzoic acid methyl ester (2b)
◦
1
Mp. 197–199 C. H NMR (300 MHz, CDCl3): d 2.87 (dd, J =
7.9 Hz, J = 1.2 Hz, 1 H), 3.25–3.20 (m, 1 H), 3.63–3.59 (m, 1
H), 3.82 (s, 3 H), 4.10 (d, J = 4.5 Hz, 1 H), 5.59–5.53 (m, 1
H), 6.23–6.18 (m, 1 H), 7.07 (d, J = 8.1 Hz, 2 H), 7.44–7.22 (m,
13 H), 7.69–7.67 (m, 2 H), 7.77 (d, J = 8.7 Hz, 2 H). 13C NMR
(125 MHz, CDCl3): d 27.4 (CH), 33.5 (CH), 43.3 (Cquat), 45.8 (CH),
46.9 (CH), 51.9 (CH3), 125.0 (CH), 126.1 (CH), 126.3 (CH), 127.2
(CH), 127.5 (CH), 128.1 (CH), 128.2 (CH), 128.3 (CH), 128.4
(CH), 129.1 (CH), 129.8 (CH), 129.8 (CH), 132.1 (CH), 135.9
(Cquat), 137.7 (Cquat), 138.5 (Cquat), 141.7 (Cquat), 141.7 (Cquat), 143.7
(Cquat), 166.8 (Cquat), 200.4 (Cquat). EI MS (70 eV, m/z (%)): 508
(M+, 100), 165 (M+ − C6H5CO, 52); HRMS (70 eV, EI) calcd. for
C36H28O3: 508.2038; found, 508.2043. IR (KBr) 1724, 1669, 1611,
1598 cm−1. Anal. calcd. for C36H28O3 (508.6): C, 85.01; H, 5.55;
found: C, 84.89; H, 5.59%.
4-(3-Benzoyl-1,1-diphenyl-indan-2-yl)-benzonitrile (3c)
◦
1
Mp. 176–178 C. H NMR (300 MHz, CDCl3): d 5.32 (d, J =
10.5 Hz, 1 H), 5.64 (d, J = 10.8 Hz, 1 H), 6.32 (d, J = 8.5 Hz, 2 H),
6.79–6.77 (m, 1 H), 6.88 (d, J = 8.0 Hz, 2 H), 7.08–6.99 (m, 3 H),
7.41–7.15 (m, 8 H), 7.63–7.49 (m, 5 H), 8.02 (d, J = 8.0 Hz, 2 H).
13C NMR (75 MHz, CDCl3): d 53.4 (CH), 57.8 (CH), 65.7 (Cquat),
110.6 (Cquat), 118.8 (Cquat), 123.6 (CH), 126.6 (CH), 126.9 (CH),
126.9 (CH), 127.2 (CH), 127.6 (CH), 128.3 (CH), 128.4 (CH),
128.9 (CH), 129.0 (CH), 129.1 (CH), 130.0 (Cquat), 130.4 (CH),
131.3 (CH), 133.8 (CH), 137.6 (Cquat), 140.4 (Cquat), 141.2 (Cquat),
144.1 (Cquat), 144.3 (Cquat), 149.0 (Cquat), 198.1 (Cquat). EI MS (70 eV,
m/z (%)): 475 (M+, 83), 370 (M+ − C6H5CO, 100); HRMS (70 eV,
EI) calcd for C35H25NO: 475.1936; found, 475.1938. IR (KBr) mmax
2233, 1682, 1618, 1608 cm−1. Anal. calcd. for C35H25NO (575.2):
C, 88.39; H, 5.30; N, 2.95; found: C, 88.36; H, 5.29; N, 2.93%.
4-(8-Benzhydrylidene-7-benzoyl-tricyclo[3.2.1.02,7]oct-3-en-6-yl)-
benzonitrile (2c)
◦
1
Mp. 174–176 C. H NMR (300 MHz, CDCl3): d 2.90 (d, J =
7.4 Hz, 1 H), 3.20 (m, 1 H), 3.60 (m, 1 H), 4.10 (d, J = 4.2 Hz, 1
H), 5.57 (m, 1H), 6.24–6.21 (m, 1 H), 7.12 (d, J = 8.1 Hz, 2 H),
7.48–7.24 (m, 15 H), 7.69 (d, J = 7.2 Hz, 2 H). 13C NMR (75 MHz,
CDCl3): d 27.4 (CH), 33.1 (CH), 43.1 (Cquart), 45.7 (CH), 46.9
(CH), 110.1 (Cquart), 118.8 (Cquart), 125.1 (CH), 126.1 (CH), 127.2
(CH), 127.3 (CH), 127.5 (CH), 128.1 (CH), 128.2 (CH), 128.5
(CH), 129.0 (CH), 129.7 (CH), 131.5 (CH), 132.2 (CH), 136.2
(Cquart), 137.1 (Cquart), 138.2 (Cquart), 141.6 (Cquart), 141.6 (Cquart),
143.9 (Cquart), 199.9 (Cquart). EI MS (70 eV, m/z (%)): 475 (M+, 100),
307 (M+ − C6H5CO, 53). HRMS (70 eV, EI) calcd. for C35H25NO:
475.1936; found: 475.1954. IR (KBr): mmax 3045 (w), 2227 (s), 1668
(s), 1608 (s), 1598 (s) cm−1. Anal. calcd. for C35H25NO (575.2): C,
88.39; H, 5.30; N, 2.95; found: C, 88.26; H, 5.34; N 2.95%.
(3,3-Diphenyl-2-p-tolyl-indan-1-yl)-phenyl-methanone (3d)
◦
1
Mp. 184–186 C. H NMR (300 MHz, CDCl3): d 2.17 (s, 3 H),
5.30 (d, J = 10.8 Hz, 1 H), 5.53 (d, J = 11.1 Hz, 1 H), 6.35 (d,
J = 6.9 Hz, 2 H), 6.65 (d, J = 8.7 Hz, 2 H), 6.79–6.76 (m, 3 H),
7.06–6.97 (m, 3 H), 7.19–7.13 (m, 3 H), 7.29–7.24 (m, 1 H), 7.37–
7.38 (m, 2 H), 7.50–7.45 (m, 2 H), 7.61–7.56 (m, 3 H), 8.00 (d, J =
7.5 Hz, 2 H). 13C NMR (75 MHz, CDCl3): d 21.0 (CH3), 53.6 (CH),
58.2 (CH), 65.4 (Cquat), 123.6 (CH), 126.3 (CH), 126.5 (CH), 126.6
(CH), 126.8 (CH), 127.3 (CH), 128.0 (CH), 128.0 (CH), 128.2
(CH), 128.8 (CH), 128.9 (CH), 129.3 (Cquat), 129.4 (CH), 130.7
4-(3-Benzoyl-1,1-diphenyl-indan-2-yl)-benzoic acid methyl ester
(3a)
◦
1
Mp. 204–205 C. H NMR (500 MHz, CDCl3): d 3.81 (s, 3 H),
5.35 (d, J = 11.0 Hz, 1 H), 5.62 (d, J = 10.5 Hz, 1 H), 6.33 (d,
This journal is
The Royal Society of Chemistry 2008
Org. Biomol. Chem., 2008, 6, 532–539 | 537
©